August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
At ESMO 2023 Dr. Breelyn Wilky presented new data from our investigational botensilimab/balstilimab combination in relapsed/refractory sarcoma
Oct 23, 2023, 13:31

At ESMO 2023 Dr. Breelyn Wilky presented new data from our investigational botensilimab/balstilimab combination in relapsed/refractory sarcoma

Agenus shared on their LinkedIn page:

“At ESMO 2023 Dr. Breelyn Wilky presented new data from our investigational botensilimab/balstilimab (BOT/BAL) combination in relapsed/refractory sarcoma, which showed durable responses across multiple subtypes. The results reinforce the potential of BOT/BAL in multiple cold, treatment-resistant solid tumors. Learn more here.”

Source: Agenus/LinkedIn